NCT01515241View on ClinicalTrials.gov

Exploratory Study of Plaque Regression

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2012

Conditions
Heterozygous Familial Hypercholesterolemia
Interventions
DRUG

CER-001

Weekly injection

Trial Locations (1)

H1T1C8

Montreal Heart Institute, Montreal

Sponsors
All Listed Sponsors
lead

Cerenis Therapeutics, SA

INDUSTRY